Study guide
Section 3.3: Neuropathic & Sensory Assessment
ABWM Certified Wound Specialist CWS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Exam Overview
1.1 About the ABWM CWS Exam 1.2 How to Use This Study Guide & Blueprint Strategy
2 Chapter 2: Comprehensive Patient & Wound Assessment
2.1 Patient History & Systemic Risk Factors 2.2 Physical Examination & Anatomical Wound Classification 2.3 Quantitative Wound Measurement & Documentation 2.4 Bioburden & Infection Assessment
3 Chapter 3: Vascular Assessment & Diagnostic Testing
Section 3.1: Ankle-Brachial Index (ABI) & Toe-Brachial Index (TBI) Interpretation Section 3.2: Advanced Vascular Diagnostics Section 3.3: Neuropathic & Sensory Assessment
4 Chapter 4: Laboratory, Imaging & Diagnostic Approaches
Section 4.1: Laboratory Evaluation in Wound Care Section 4.2: Imaging Modalities for Wounds & Bone Section 4.3: Differential Diagnosis of Recalcitrant & Atypical Wounds
5 Chapter 5: Physiology of Wound Healing & Tissue Repair
5.1 Hemostasis & Inflammatory Phase Dynamics 5.2 Proliferative & Remodeling Phases 5.3 Growth Factors & Extracellular Matrix (ECM)
6 Chapter 6: Biofilm Biology & Wound Bed Preparation
6.1 Biofilm Pathophysiology & Management Strategies 6.2 TIME Framework & Wound Bed Preparation 6.3 Moisture Balance & Exudate Management
7 Chapter 7: Pressure Injuries & Moisture-Associated Skin Damage
7.1 Pressure Injury Pathophysiology & NPIAP Staging 7.2 Risk Assessment Tools & Support Surface Selection 7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis
8 Chapter 8: Lower Extremity Ulcers (Venous, Arterial & Mixed)
Section 8.1: Venous Leg Ulcers & CEAP Classification Section 8.2: Arterial Ulcers & Peripheral Artery Disease Section 8.3: Mixed Venous-Arterial Ulcers & Lymphedema
9 Chapter 9: Diabetic Foot Ulcers & Neuropathic Wounds
Section 9.1: Diabetic Foot Ulcer Pathophysiology & Classification Section 9.2: Diabetic Foot Infection & Osteomyelitis Management
10 Chapter 10: Thermal Injuries, Surgical Wounds & Special Etiologies
Section 10.1: Burn Injuries & Thermal Damage Section 10.2: Surgical Wounds, Dehisced Incisions & Fistulas Section 10.3: Dermatological, Pediatric & Miscellaneous Wound Types
11 Chapter 11: Debridement & Topically Applied Therapies
Section 11.1: Debridement Modalities & Selection Section 11.2: Wound Dressing Selection & Categories Section 11.3: Topical Antimicrobial Agents & Antiseptics
12 Chapter 12: Compression Therapy & Advanced Off-Loading
Section 12.1: Compression Therapy Modalities & Science Section 12.2: Off-Loading Devices & Biomechanical Protection
13 Chapter 13: Advanced & Adjunctive Wound Therapies
Section 13.1: Negative Pressure Wound Therapy (NPWT) Section 13.2: HBOT, Biophysical Agents & Advanced Biologics Section 13.3: Systemic Nutrition, Hydration & Pain Management
14 Chapter 14: Professional Practice, Reimbursement & Interprofessional Care
14.1 Professional Ethics, Scope of Practice & ABWM Guidelines 14.2 Documentation, Coding & Reimbursement Standards 14.3 Interprofessional Team Roles & Quality Improvement
Section 3.3: Neuropathic & Sensory Assessment
Key Takeaways Explain This Topic AI
The 10-gram (5.07 calibrated) Semmes-Weinstein monofilament test evaluates Loss of Protective Sensation (LOPS); failure to perceive the monofilament at even a single standard site out of 10 anatomical plantar locations establishes LOPS and high ulceration risk.
Vibratory sensation testing using a 128 Hz tuning fork at the distal interphalangeal joint of the hallux evaluates large-fiber (A-beta) sensory nerve dysfunction, serving as an early indicator of diabetic peripheral neuropathy.
Achilles tendon reflex (S1 nerve root) evaluation tests deep tendon reflexes; hyporeflexia or complete areflexia provides objective clinical confirmation of distal symmetrical peripheral polyneuropathy.
Autonomic neuropathy causes sudomotor dysfunction resulting in anhidrosis, dry fissured skin, and arteriovenous (AV) shunting, which creates a falsely warm foot with bounding pulses despite capillary tissue hypoxia.
Charcot Neuropathic Osteoarthropathy is a devastating neuro-inflammatory complication presenting as a warm, swollen, erythematous foot (temperature differential >2°C / 3.6°F) that can progress to joint destruction and rocker-bottom foot deformity.
Last updated: July 2026
Section 3.3: Neuropathic & Sensory Assessment
Core Clinical Principle: Diabetic peripheral neuropathy is the single greatest independent risk factor for lower extremity foot ulceration. Neuropathy impairs sensory perception, alters foot biomechanics, and abolishes autonomic skin protection, creating the ideal conditions for painless tissue breakdown.
A comprehensive lower extremity sensory and neuropathic examination is mandatory for all patients presenting with diabetic foot ulcers, metabolic disorders, or suspected neurological dysfunction. Assessment must encompass all three arms of the peripheral nervous system: sensory , motor , and autonomic pathways.
Pathophysiology of Diabetic Peripheral Neuropathy
Chronic persistent hyperglycemia induces metabolic damage to peripheral nerves through multiple pathophysiological cascades:
Polyol Pathway Activation: Intracellular accumulation of sorbitol and fructose induces osmotic stress and cellular edema in Schwann cells.
Advanced Glycation End-Products (AGEs): Non-enzymatic glycation of structural nerve proteins damages axonal transport structures.
Vasa Nervorum Microvascular Ischemia: Endothelial proliferation and basement membrane thickening of the vasa nervorum (nutrient capillaries supplying peripheral nerves) cause chronic ischemic hypoxia of nerve fibers.
Sensory Neuropathy Evaluation: 10-Gram Semmes-Weinstein Monofilament
The 10-gram Semmes-Weinstein Monofilament (size 5.07 calibrated target force) is the clinical gold standard for identifying Loss of Protective Sensation (LOPS) .
The Concept of Protective Sensation
Protective sensation is the neurological feedback mechanism that alerts an individual to microtrauma, foreign objects inside footwear, repetitive shear stress, or excessive pressure. When protective sensation is lost, repetitive mechanical stress causes sub-epidermal tissue hemorrhage and ulceration without causing pain.
Monofilament Testing Protocol & Technique
Patient Preparation: The patient sits or lies supine with eyes closed. First, demonstrate the monofilament touch on the patient's arm or sternum so they recognize the sensation.
Application Technique: Hold the monofilament perpendicular to the skin surface. Press the filament smoothy until it buckles (bends into a C-shape), which delivers exactly 10 grams of force. Hold in place for 1.5 seconds , then lift.
Crucial Testing Rules: Do NOT apply the monofilament directly over calluses, hyperkeratotic tissue, necrotic eschar, or open ulcerations, as thickened tissue yields false-negative responses. Avoid sliding or dragging the filament across the skin.
10 Anatomical Plantar Testing Sites & Diagnostic LOPS Criteria
Testing must systematically cover 10 designated anatomical sites across the plantar surface and dorsum of each foot:
Site Category Specific Anatomical Testing Site Clinical Rationale
Distal Digits (Toes) 1. Plantar hallux (distal phalanx); 2. Plantar 3rd toe; 3. Plantar 5th toe Evaluates distal nerve terminals susceptible to early dying-back neuropathy
Metatarsal Heads 4. Plantar 1st metatarsal head; 5. Plantar 3rd metatarsal head; 6. Plantar 5th metatarsal head Major weight-bearing pressure points vulnerable to peak vertical shear forces
Midfoot & Heel 7. Plantar medial midfoot; 8. Plantar lateral midfoot; 9. Plantar heel center Midfoot and calcaneal tissue evaluation
Dorsum of Foot 10. Dorsal web space between 1st & 2nd digits Evaluates deep peroneal nerve sensory branch
Diagnostic LOPS Criterion: Inability to perceive the monofilament touch at 1 or more sites out of the 10 standard sites confirms Loss of Protective Sensation (LOPS) and classifies the patient at high risk for neuropathic foot ulceration.
Large-Fiber Sensory Testing: 128 Hz Tuning Fork & Biothesiometer
While the 10g monofilament evaluates small-to-medium myelinated nerve fibers, evaluating vibratory perception tests large myelinated A-beta sensory nerve fibers .
128 Hz Tuning Fork Protocol
A 128 Hz tuning fork is struck against the examiner's palm to initiate vibration.
The base of the vibrating tuning fork is placed perpendicular to the bony prominence of the distal interphalangeal (DIP) joint of the hallux .
The patient, with eyes closed, must report when they first feel the vibration and the exact moment the vibration stops.
Impaired Vibratory Sensation: If the examiner continues to feel vibration for >8–10 seconds after the patient reports cessation of vibration, vibratory sensation is significantly diminished. If absent at the hallux, testing proceeds proximally to the medial malleolus and tibial tuberosity.
Quantitative Vibration Perception Threshold (VPT) / Biothesiometer
A Biothesiometer (or Neurothesiometer) provides quantitative digital measurement of vibration perception threshold in Volts.
VPT > 25 Volts: Strongly diagnostic of severe large-fiber peripheral neuropathy and independently predicts a 7-fold increase in 4-year foot ulceration risk.
Deep Tendon Reflexes: Achilles (S1) Evaluation
Evaluating the Achilles Tendon Reflex (Ankle Jerk) tests the integrity of the S1 nerve root reflex arc:
The patient rests with the foot dorsiflexed to slight tension.
The Achilles tendon is struck sharply with a reflex hammer.
Grading: Reflexes are graded from 0 (absent) to 4+ (clonus).
Clinical Significance: Hyporeflexia (1+) or complete areflexia (0) of the Achilles reflex is a key clinical physical finding confirming distal symmetrical peripheral polyneuropathy.
Autonomic Neuropathy & Sudomotor Dysfunction
Autonomic neuropathy damages sympathetic nerve fibers supplying sweat glands, sebaceous glands, and peripheral vascular smooth muscle. It produces profound alterations in foot physiology.
Pathophysiological Mechanism Clinical Presentation & Physical Findings Secondary Complications & Risks
Sudomotor Dysfunction (Anhidrosis) Complete loss of sweating; dry, cracked, scaly skin Loss of skin elasticity; deep heel fissures that serve as portals for bacterial infection
Sympathetic Auto-Sympathectomy Loss of vascular smooth muscle tone; arteriovenous (AV) shunting Blood bypasses capillaries into venous circulation; produces a falsely warm foot with bounding pedal pulses despite deep tissue hypoxia
Motor Neuropathy (Intrinsic Muscle Atrophy) Atrophy of lumbrical and interosseous foot muscles Loss of flexor/extensor balance; produces claw toes, hammer toes, elevated plantar arch, and prominent metatarsal heads
Charcot Neuropathic Osteoarthropathy (Charcot Foot)
Charcot Neuropathic Osteoarthropathy is a non-infectious, destructive neuro-inflammatory bone and joint condition occurring in patients with severe peripheral neuropathy.
Pathogenesis & Eichenholtz Stages
Unperceived microtrauma in a neuropathic foot triggers massive pro-inflammatory cytokine release (TNF-alpha, IL-1beta), leading to RANKL-mediated hyperemic osteoclast activation, osteolysis, microfractures, joint dislocation, and structural arch collapse ( rocker-bottom foot deformity ).
Eichenholtz Stage 0 (Inflammatory / Pre-Radiographic): Severe localized erythema, edema, hyperthermia (>2°C skin temperature difference compared to contralateral limb); radiographs normal.
Eichenholtz Stage 1 (Development / Fragmentation): Joint subluxation, bone fragmentation, arch collapse visible on X-ray.
Eichenholtz Stage 2 (Coalescence): Absorption of fine debris; fusion of larger bone fragments.
Eichenholtz Stage 3 (Reconstruction / Remodeling): Bone remodeling and ankylosis; permanent structural deformity.
Critical Clinical Rule for Differential Diagnosis
A red, hot, swollen neuropathic foot with a skin temperature differential > 2°C (3.6°F) compared to the contralateral limb MUST be treated as Stage 0 Charcot Foot (requiring immediate Total Contact Casting off-loading) until proven otherwise; it is frequently misdiagnosed as cellulitis, gout, or osteomyelitis.